Neonc Technologies Holdings (NTHI) Interest Expenses (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Interest Expenses of $982624.0 for Q1 2026, up 218.08% year-over-year from $308922.0 in Q1 2025, and down 23.06% quarter-over-quarter from $1.3 million in Q4 2025.
Neonc Technologies Holdings (NTHI) Interest Expenses (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Interest Expenses for 3 consecutive years, with $982624.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 218.08% year-over-year to $982624.0; the TTM figure through Mar 2026 stood at $3.4 million (up 132.57% YoY), while the FY2025 annual figure was $30.8 million, up 126.19% from the prior year.
- Interest Expenses fell to $982624.0 in Q1 2026 per NTHI's latest filing, from $1.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $1.4 million in Q1 2024 and bottomed at -$2401.0 in Q4 2024.
- Historically, Interest Expenses has averaged $760803.0 across 3 years, with a median of $926219.5 in 2025.
- On a YoY basis, Interest Expenses climbed as much as 53289.5% in 2025 and fell as far as 92.24% in 2025.
- Neonc Technologies Holdings' Interest Expenses stood at -$2401.0 in 2024, then surged by 53289.5% to $1.3 million in 2025, then slipped by 23.06% to $982624.0 in 2026.
- Business Quant data shows NTHI's Interest Expenses at $982624.0 in Q1 2026, $1.3 million in Q4 2025, and $869815.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | 234,370.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 356,481.00 |
| Jun 30, 2026 | 356,481.00 |
| Mar 31, 2026 | 982,624.00 |
| Mar 31, 2026 | 982,624.00 |
| Dec 31, 2025 | 1.28 Mn |
| Dec 31, 2025 | 1.28 Mn |
| Sep 30, 2025 | 869,815.00 |
| Sep 30, 2025 | 869,815.00 |
| Jun 30, 2025 | 90,928.00 |
| Jun 30, 2025 | 90,928.00 |
| Mar 31, 2025 | 308,922.00 |
| Mar 31, 2025 | 308,922.00 |
| Dec 31, 2024 | -2,401.00 |
| Dec 31, 2024 | -2,401.00 |
| Jun 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.39 Mn |
| Mar 31, 2024 | 1.39 Mn |